Statistic | three-point scale | five-point scale | nine-point scale | Sensitivity analysis | |
---|---|---|---|---|---|
five-point scalea | nine-point scalea | ||||
Overallb | |||||
Changes in 2nd survey (in %) | 12.48 | 24.73 | 32.26 | 20.96 | 8.57 |
Class imbalancea 1st survey (in %) | 79.16 | 64.93 | 63.62 | 64.93 | 88.25 |
Test-retest agreement (in %) | 87.52 | 75.27 | 67.74 | 79.04 | 91.43 |
Weighted kappa [95% CI] | 0.63 [0.62; 0.64] | 0.47 [0.07; 0.86] | 0.78 [0.78; 0.78] | 0.54 [0.50; 0.58] | 0.58 [0.55; 0.62] |
Mean [range] over the 19 proposed treatment goals | |||||
Changes in 2nd survey (in %) | 12.60 [2.41; 25.61] | 24.75 [16.05; 38.82] | 32.43 [17.07; 55.13] | 20.96 [16.05; 28.24] | 8.69 [0.00; 24.00] |
Class imbalancec 1st survey (in %) | 0.80 [49.38; 95.35] | 66.05 [35.71; 83.13] | 63.46 [21.25; 81.18] | 68.65 [45.78; 83.13] | 88.19 [37.50; 100.00] |
Test-retest agreement (in %) | 87.40 [74.39; 97.59] | 75.25 [61.18; 83.95] | 67.57 [44.87; 82.93] | 79.04 [71.76; 83.95] | 91.31 [76.00; 100.00] |
Weighted kappa | 0.55 [0.18; 0.87] | 0.44 [0.29; 0.62] | 0.61 [0.17; 0.81] | 0.49 [0.35; 0.67] | 0.40 [0.00; 0.80] |